These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9380930)

  • 1. [Clinical usefulness of positron emission tomography (PET) in the evaluation of myocardial viability].
    Coma-Canella I; García Velloso MJ
    Rev Esp Cardiol; 1997 Sep; 50(9):605-11. PubMed ID: 9380930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.
    Di Carli MF; Asgarzadie F; Schelbert HR; Brunken RC; Rokhsar S; Maddahi J
    J Nucl Cardiol; 1998; 5(6):558-66. PubMed ID: 9869477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.
    Schöder H; Campisi R; Ohtake T; Hoh CK; Moon DH; Czernin J; Schelbert HR
    J Am Coll Cardiol; 1999 Apr; 33(5):1328-37. PubMed ID: 10193735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steps forward in the assessment of myocardial viability in left ventricular dysfunction.
    Udelson JE
    Circulation; 1998 Mar; 97(9):833-8. PubMed ID: 9521330
    [No Abstract]   [Full Text] [Related]  

  • 5. [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?
    Srinivasan G; Kitsiou AN; Bacharach SL; Bartlett ML; Miller-Davis C; Dilsizian V
    Circulation; 1998 Mar; 97(9):843-50. PubMed ID: 9521332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of thallium scintigraphy and positron emission tomography.
    Niemeyer MG; Kuijper AF; Meeder JG; Cramer MJ; Cleophas AJ; van der Wall EE
    Angiology; 1997 Oct; 48(10):843-53. PubMed ID: 9342963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-18-fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function.
    Beanlands RS; deKemp RA; Smith S; Johansen H; Ruddy TD
    Am J Cardiol; 1997 Apr; 79(8):1092-5. PubMed ID: 9114769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?
    Kalff V; Berlangieri SU; Van Every B; Rowe JL; Lambrecht RM; Tochon-Danguy HJ; Egan GF; McKay WJ; Kelly MJ
    Eur J Nucl Med; 1995 Jul; 22(7):625-32. PubMed ID: 7498223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
    Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction.
    Marin-Neto JA; Dilsizian V; Arrighi JA; Perrone-Filardi P; Bacharach SL; Bonow RO
    Am J Cardiol; 1998 Nov; 82(9):1001-7. PubMed ID: 9817471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial viability: seeking relevance and redefinition.
    Arrighi JA; Soufer R
    J Nucl Cardiol; 1998; 5(6):629-33. PubMed ID: 9869486
    [No Abstract]   [Full Text] [Related]  

  • 14. 13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization.
    Kitsiou AN; Bacharach SL; Bartlett ML; Srinivasan G; Summers RM; Quyyumi AA; Dilsizian V
    J Am Coll Cardiol; 1999 Mar; 33(3):678-86. PubMed ID: 10080468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction.
    Czernin J; Porenta G; Brunken R; Krivokapich J; Chen K; Bennett R; Hage A; Fung C; Tillisch J; Phelps ME
    Circulation; 1993 Sep; 88(3):884-95. PubMed ID: 8353915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction.
    Wolpers HG; Burchert W; van den Hoff J; Weinhardt R; Meyer GJ; Lichtlen PR
    Circulation; 1997 Mar; 95(6):1417-24. PubMed ID: 9118508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.
    Marshall RC; Tillisch JH; Phelps ME; Huang SC; Carson R; Henze E; Schelbert HR
    Circulation; 1983 Apr; 67(4):766-78. PubMed ID: 6600659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT.
    Döbert N; Britten M; Assmus B; Berner U; Menzel C; Lehmann R; Hamscho N; Schächinger V; Dimmeler S; Zeiher AM; Grünwald F
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1146-51. PubMed ID: 15064873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.